Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Intuitive Surgical broadens its da Vinci SP system with FDA clearance for three new surgeries, expanding its role in minimally invasive care.
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $566.89, signifying a -1.47% move from its prior day's close.
Intuitive Surgical's golden crossover arrives amid surging procedures and rapid dV5 adoption, raising the stakes for its bullish momentum.
Intuitive Surgical (ISRG) stock may represent a worthwhile investment at present. Why? Because you receive high margins – indicative of pricing power and cash generation capability – at a discounted price.
Intuitive Surgical (ISRG) stock may represent a worthwhile investment at present. Why? Because you receive high margins – indicative of pricing power and cash generation capability – at a discounted price.
Intuitive Surgical's strong growth contrasts with tariff-driven margin pressure, raising questions about its ability to hold gross margins near 67%.
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $567.37, denoting a -1.07% move from the preceding trading day.
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Intuitive Surgical (ISRG) stock may be a solid investment at this time. Why? Because you're getting high margins – indicative of pricing power and cash generation capability – for a discounted price.
ISRG leverages refurbished Xi systems to reach cost-sensitive markets and expand access beyond hospitals.
Intuitive Surgical's robotics surge and Medtronic's broad innovation push set the stage for a high-tech showdown in next-gen minimally invasive care.